News

A group of scientists in Japan has discovered that fermented stevia, a plant commonly used as a calorie-free sweetener, may ...
The Diffuse Large B-cell Lymphoma (DLBCL) market is witnessing significant growth, driven by advancements in targeted immunotherapies like CAR-T cell therapy and bispecific antibodies. These therapies ...
Chemotherapy-induced nausea and vomiting are among the most distressing side effects of anti-cancer treatment, particularly for those receiving highly ...
A hormone-free pill, known as YCT-529, that temporarily stops sperm production by blocking a vitamin A metabolite, has concluded its first safety trial in humans, getting a step closer to increasing ...
"It was a lot of treatment. Some people assume that once cancer treatment ends, everything goes back to normal but I’m still ...
A new study from Professor Vadim Backman shows that restoring cellular memory prevents cancer cells’ ability to adapt to evade treatment.
While CIML natural killer immunotherapy can result in infection-like reactions, required prior chemo may cause infections, ...
The latest wave of value creators to emerge from Babraham Research Campus’ Accelerate@Babraham accelerator used skills honed ...
New long-term data from the Phase III FLAURA2 trial confirm that Tagrisso combined with chemotherapy delivers a significant overall survival benefit over monotherapy in patients with advanced ...
A new study published in Nanotechnology offers new hope for less harmful breast cancer therapy by combining two powerful, non ...